Meet with Cromos Pharma during the San Antonio Breast Cancer Symposium
Cromos Pharma is delighted to be taking part again in this year’s San Antonio Breast Cancer Symposium (SABCS), 7-10 December, 2021. This is the 44th year of the event which attracts a broad spectrum of researchers, health professionals, and those with a special interest in breast cancer. Arrange a meeting with Cromos Pharma’s US Business Development Director, Nicole Brenna during the event by emailing bd@cromospharma.com.
Cromos Pharma’s breast cancer expertise
Cromos Pharma has over 16 years of experience in delivering clinical trial success in breast cancer studies. Since 2004, we have conducted dozens of trials involving thousands of breast cancer patients. These studies have focused on a range of areas from finding innovative targeted therapies to biosimilar and generic studies aimed at offering wider access to novel treatments. In 2019, our team successfully recruited almost 500 patients (92% of total) for a multi-country breast cancer study in just seven months. Cromos Pharma conducts breast cancer studies for international and regional pharma, as well as biotechcompanies, including the 3 of the top 10 pharma companies (Roche, Novartis and Pfizer) in the world. We offer a flexible oncology model focused on optimized study design combined with rapid patient enrollment, to accelerate data delivery.
Exceptional patient recruitment and retention
Cromos Pharma combines global expertise with in-depth experience and knowledge in Central and Eastern Europe to offer exceptional patient recruitment. In our 16 year history, our team has met or reduced enrollment timelines in 95% of trials conducted. Responsible recruitment is supported by our “No Patients-No Payment” initiative – a unique risk-sharing program.
Rapid start-up and high quality data
We provide the most optimized start-up timelines in our regions. We regularly achieve regulatory approvals in Georgia, within two months of project signing. Regulatory inspections and site audits also attest to the highest quality of our clinical data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection).
About Cromos Pharma
Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.
Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Turkey to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials.
We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.
Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.
